CNP
55
-4
EFX
52
2
FITB
73
-3
NEE
52
2
PHM
43
-3
MS
69
-3
EA
46
2
CME
42
-8
OI
58
-2
ESS
45
-2
SBUX
45
5
CMA
65
-6
LMT
55
-4
AON
67
2
PEP
35
-3
RCL
64
2
KMX
47
3
WM
57
-2
MTB
69
-7
HUM
42
8
CNP
55
-4
EFX
52
2
FITB
73
-3
NEE
52
2
PHM
43
-3
MS
69
-3
EA
46
2
CME
42
-8
OI
58
-2
ESS
45
-2
SBUX
45
5
CMA
65
-6
LMT
55
-4
AON
67
2
PEP
35
-3
RCL
64
2
KMX
47
3
WM
57
-2
MTB
69
-7
HUM
42
8
Financhill
Back

The Gorman-Rupp Co. Vs. Novo Nordisk A/S Industry Stock Comparison

Buy
73

GRC
The Gorman-Rupp Co.

Last Price:
$49.17
Seasonality Move:
2.21%
Sell
20

NVO
Novo Nordisk A/S

Last Price:
$48.11
Seasonality Move:
4.04%
Buy
73
The Gorman-Rupp Co. (GRC) is a Buy

Is The Gorman-Rupp Co. a Buy, Sell or Hold?

  • The current The Gorman-Rupp Co. [GRC] share price is $49.10. The Score for GRC is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • GRC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NVO] share price is $47.61. The Score for NVO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GRC Stock Price Chart

What is The Gorman-Rupp Co.'s stock price today?

  • The The Gorman-Rupp Co. share price today is $49.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRC is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $47.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

GRC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.04 Buy
Relative Strength Index (14 RSI): 62.22 Buy
Chaikin Money Flow: 145907 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.66 - 48.68) Buy
Bollinger Bands (100): (42.59 - 47.11) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 44.82 Sell
Chaikin Money Flow: -6318846 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

GRC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.25 Sell
20-day SMA: 47.34 Buy
50-day SMA: 46.21 Buy
200-day SMA: 40.72 Buy
8-day EMA: 48.74 Buy
20-day EMA: 47.66 Buy
50-day EMA: 46.32 Buy
200-day EMA: 42.38 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.82 Sell
20-day SMA: 48.1 Sell
50-day SMA: 50.21 Sell
200-day SMA: 61.08 Sell
8-day EMA: 48.51 Sell
20-day EMA: 48.56 Sell
50-day EMA: 50.31 Sell
200-day EMA: 63.25 Sell

The Gorman-Rupp Co. Earnings Growth & GRC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.24 per share.

Novo Nordisk A/S Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.16 per share.

The Gorman-Rupp Co. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):